We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation (Resistance)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00312039
Recruitment Status : Completed
First Posted : April 7, 2006
Last Update Posted : January 22, 2014
Information provided by:
Achillion Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2007
  Study Completion Date : October 2007